相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antibodies to watch in 2022
Helene Kaplon et al.
MABS (2022)
Identification of the specific causes of polysorbate 20 degradation in monoclonal antibody formulations containing multiple lipases
Sisi Zhang et al.
PHARMACEUTICAL RESEARCH (2022)
Improving Antibody Therapeutics by Manipulating the Fc Domain: Immunological and Structural Considerations
George Delidakis et al.
ANNUAL REVIEW OF BIOMEDICAL ENGINEERING (2022)
Biopharmaceutical Manufacturing: Historical Perspectives and Future Directions
Alana C. Szkodny et al.
ANNUAL REVIEW OF CHEMICAL AND BIOMOLECULAR ENGINEERING (2022)
Reversibility and irreversibility in the temperature denaturation of monoclonal antibodies
Arne Schon et al.
ANALYTICAL BIOCHEMISTRY (2021)
Impact of IgG subclass on molecular properties of monoclonal antibodies
Yu Tang et al.
MABS (2021)
Physicochemical Stability of Monoclonal Antibodies: A Review
Yoann Le Basle et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Engineering a human IgG2 antibody stable at low pH
Seiji Saito et al.
PROTEIN SCIENCE (2020)
Characterization of IgG1 Fc Deamidation at Asparagine 325 and Its Impact on Antibody-dependent Cell-mediated Cytotoxicity and FcγRIIIa Binding
Xiaojun Lu et al.
SCIENTIFIC REPORTS (2020)
Glycan engineering reveals interrelated effects of terminal galactose and core fucose on antibody-dependent cell-mediated cytotoxicity
Qingchun Zhang et al.
BIOTECHNOLOGY PROGRESS (2020)
A single molecular descriptor to predict solution behavior of therapeutic antibodies
Jonathan S. Kingsbury et al.
SCIENCE ADVANCES (2020)
Effects of terminal galactose residues in mannose α1-6 arm of Fc-glycan on the effector functions of therapeutic monoclonal antibodies
Michihiko Aoyama et al.
MABS (2019)
Protein aggregation and mitigation strategy in low pH viral inactivation for monoclonal antibody purification
Weixin Jin et al.
MABS (2019)
Structure Based Prediction of Asparagine Deamidation Propensity in Monoclonal Antibodies
Qingrong Yan et al.
MABS (2018)
Engineering the hinge region of human IgG1 Fc-fused bispecific antibodies to improve fragmentation resistance
Saori Suzuki et al.
SCIENTIFIC REPORTS (2018)
Specific Immune Response to Phospholipase B-Like 2 Protein, a Host Cell Impurity in Lebrikizumab Clinical Material
Saloumeh Kadkhodayan Fischer et al.
AAPS JOURNAL (2017)
Knockout of a difficult-to-remove CHO host cell protein, lipoprotein lipase, for improved polysorbate stability in monoclonal antibody formulations
Josephine Chiu et al.
BIOTECHNOLOGY AND BIOENGINEERING (2017)
An Fc-Silenced IgG1 Format With Extended Half-Life Designed for Improved Stability
M. Jack Borrok et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Forced degradation of recombinant monoclonal antibodies: A practical guide
Christine Nowak et al.
MABS (2017)
Optimizing antibody expression: The nuts and bolts
B. Vijayalakshmi Ayyar et al.
METHODS (2017)
The N-glycosylation of Mouse immunoglobulin G (igg)-Fragment crystallizable Differs Between igg subclasses and strains
Noortje de Haan et al.
FRONTIERS IN IMMUNOLOGY (2017)
Subclass-specific IgG glycosylation is associated with markers of inflammation and metabolic health
Rosina Plomp et al.
SCIENTIFIC REPORTS (2017)
Functional, Biophysical, and Structural Characterization of Human IgG1 and IgG4 Fc Variants with Ablated Immune Functionality
Susan H. Tam et al.
ANTIBODIES (2017)
A Novel Sample Preparation for Shotgun Proteomics Characterization of HCPs in Antibodies
Lihua Huang et al.
ANALYTICAL CHEMISTRY (2017)
Monoclonal Antibodies Follow Distinct Aggregation Pathways During Production-Relevant Acidic Incubation and Neutralization
Thomas Skamris et al.
PHARMACEUTICAL RESEARCH (2016)
Advances in recombinant antibody manufacturing
Renate Kunert et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2016)
Polysorbates 20 and 80 Degradation by Group XV Lysosomal Phospholipase A2 Isomer X1 in Monoclonal Antibody Formulations
Troii Hall et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Fc-galactosylation modulates antibody-dependent cellular cytotoxicity of therapeutic antibodies
Marco Thomann et al.
MOLECULAR IMMUNOLOGY (2016)
Therapeutic Antibody Engineering To Improve Viscosity and Phase Separation Guided by Crystal Structure
Chi-Kin Chow et al.
MOLECULAR PHARMACEUTICS (2016)
Protein A chromatography increases monoclonal antibody aggregation rate during subsequent low pH virus inactivation hold
Alice R. Mazzer et al.
JOURNAL OF CHROMATOGRAPHY A (2015)
Identification and Characterization of Host Cell Protein Product-Associated Impurities in Monoclonal Antibody Bioprocessing
Nicholas E. Levy et al.
BIOTECHNOLOGY AND BIOENGINEERING (2014)
Small-Angle X-ray Scattering Screening Complements Conventional Biophysical Analysis: Comparative Structural and Biophysical Analysis of Monoclonal Antibodies IgG1, IgG2, and IgG4
Xinsheng Tian et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Stability of Monoclonal Antibodies at High-Concentration: Head-to-Head Comparison of the IgG1 and IgG4 Subclass
Martin S. Neergaard et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
High-Throughput Screening and Stability Optimization of Anti-Streptavidin IgG1 and IgG2 Formulations
Larysa Alekseychyk et al.
JOURNAL OF BIOMOLECULAR SCREENING (2014)
Effects of subclass change on the structural stability of chimeric, humanized, and human antibodies under thermal stress
Takahiko Ito et al.
PROTEIN SCIENCE (2013)
Relative stabilities of IgG1 and IgG4 Fab domains: Influence of the light-heavy interchain disulfide bond architecture
James T. Heads et al.
PROTEIN SCIENCE (2012)
Fragmentation of a Highly Purified Monoclonal Antibody Attributed to Residual CHO Cell Protease Activity
Sharon X. Gao et al.
BIOTECHNOLOGY AND BIOENGINEERING (2011)
Opalescence of an IgG2 Monoclonal Antibody Solution as it Relates to Liquid-Liquid Phase Separation
Bruce D. Mason et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
The in vitro resistance of IgG2 to proteolytic attack concurs with a comparative paucity of autoantibodies against peptide analogs of the IgG2 hinge
Randall J. Brezski et al.
MABS (2011)
Fragmentation of monoclonal antibodies
Josef Vlasak et al.
MABS (2011)
Acid-Induced Aggregation of Human Monoclonal IgG1 and IgG2: Molecular Mechanism and the Effect of Solution Composition
Sanjay B. Hari et al.
BIOCHEMISTRY (2010)
Influence of pH on Heat-Induced Aggregation and Degradation of Therapeutic Monoclonal Antibodies
Tomoyoshi Ishikawa et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2010)
Intrachain disulfide bond in the core hinge region of human IgG4
James W. Bloom et al.
PROTEIN SCIENCE (2010)
Increased aggregation propensity of IgG2 subclass over IgG1: Role of conformational changes and covalent character in isolated aggregates
Heather Franey et al.
PROTEIN SCIENCE (2010)
Separation and characterization of an IgG2 antibody containing a cyclic imide in CDR1 of light chain by hydrophobic interaction chromatography and mass spectrometry
John Valliere-Douglass et al.
ANALYTICAL CHEMISTRY (2008)
Heterogeneity of Monoclonal Antibodies Revealed by Charge-Sensitive Methods
J. Vlasak et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2008)
A broad range of Fab stabilities within a host of therapeutic IgGs
Ellen Garber et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
分享论文
